Last reviewed · How we verify
NCT04950959
XACT ACE Observational Registry
trial testing Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T in Tumors in 500 participants. Currently enrolling.
1 July 2026
Quick facts
| Lead sponsor | Xact Robotics Ltd. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 October 2021 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 August 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T
Conditions studied
- Tumors — all drugs for Tumors →
Sponsor
Xact Robotics Ltd.
Who can join
18 and older, any sex, with Tumors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Compile real world data on the use of the XACT ACE Robotic System
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04950959
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tumors
Currently open trials in the same condition.
- NCT05697406 — HP Pyruvate MRI in Cancers · Phase 1, PHASE2 · recruiting
- NCT05103358 — Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 G · Phase 2 · active not recruiting
- NCT05103969 — Cohort of Tumors With POLE/D1 Mutation · recruiting
- NCT04341181 — ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling · Phase 2 · recruiting
- NCT05733091 — Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors · recruiting
Other Xact Robotics Ltd. trials
Trials by the same sponsor.
- NCT04651517 — Pilot Study of the ACE System in Lung Procedures · NA · completed
- NCT03008603 — Evaluation of the Safety, Effectiveness & Usability of the XACT Robotic System for Image Guided Percutaneous Procedures · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04950959 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xact Robotics Ltd.
- Last refreshed: 21 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04950959.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing